Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 2/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30110738 | 1.00 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL18858530 | 0.85 | PDE3B (0.44) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL28250134 | 0.84 | FDPS (0.42) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL10203039 | 0.77 | CACNA2D1 (0.35) | CACNA2D1CYP2D6HRH1NOS3NOS1 | |
| SCHEMBL30610258 | 0.76 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL13980103 | 0.76 | PDE3B (0.40) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL11786386 | 0.74 | PDE3B (0.39) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL10964015 | 0.74 | PDE3B (0.39) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL9953172 | 0.74 | PDE3B (0.39) | PDE3BPDE3AKDM4EUSP2HPGD | |
| SCHEMBL28235835 | 0.74 | KDM4E (0.42) | PDE3BPDE3AKDM4EUSP2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096585-A1 | ORAL COMPOSITION | KAO CORPORATION (JP) | 2026-04-09 | — | — | US | claimed |
| EP-4591720-A1 | ORAL COMPOSITION | Kao Corporation (JP) | 2025-07-30 | — | — | EP | claimed |
| CN-119908504-A | Electronic atomization liquid with sweet taste, preparation method and electronic atomization device | 思摩尔国际控股有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119655345-A | Coffee replica made from a single component | 航行食品股份有限公司 | 2025-03-21 | — | — | CN | claimed |
| US-20250008978-A1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. | 2025-01-09 | — | — | US | claimed |
| EP-4470389-A2 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2024-12-04 | — | — | EP | claimed |
| CN-119009136-A | Pyrazinyl eutectic electrolyte with wide electrochemical stability window, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-11-22 | — | — | CN | claimed |
| CN-118914433-A | Method for simultaneously separating multiple groups of isomers and quantitatively detecting 24 pyrazine compounds | 泸州品创科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| EP-3930472-B1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-09-11 | — | — | EP | claimed |
| US-20240260600-A1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. | 2024-08-08 | — | — | US | claimed |
| EP-2931236-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| EP-2931854-A1 | FRAGRANCE MATERIALS | The Procter & Gamble Company (US) | 2015-10-21 | — | — | EP | claimed |
| CN-104902869-A | Personal care compositions | PROCTER & GAMBLE | 2015-09-09 | — | — | CN | claimed |
| CN-104837973-A | Fragrance materials | PROCTER & GAMBLE | 2015-08-12 | — | — | CN | claimed |
| US-20140179722-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-26 | — | — | US | claimed |
| WO-2014093807-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| US-20140170194-A1 | FRAGRANCE MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| WO-2014093819-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
| WO-2014093747-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | PDE3B 655/4885PDE3A 372/4885KDM4E 1936/4885 |
| US-20260096585-A1 | ORAL COMPOSITION | TAS2R5, TAS2R16, TAS2R45 | PDE3B 965/4885PDE3A 884/4885KDM4E 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.